Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) by 40.1% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 549,686 shares of the semiconductor company’s stock after acquiring an additional 157,446 shares during the period. Barrow Hanley Mewhinney & Strauss LLC’s holdings in Axcelis Technologies were worth $72,108,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of ACLS. Heritage Family Offices LLP acquired a new position in Axcelis Technologies during the 3rd quarter worth $60,000. Parallel Advisors LLC boosted its stake in Axcelis Technologies by 22.0% during the first quarter. Parallel Advisors LLC now owns 665 shares of the semiconductor company’s stock valued at $62,000 after buying an additional 120 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in Axcelis Technologies by 25.9% during the third quarter. MassMutual Private Wealth & Trust FSB now owns 598 shares of the semiconductor company’s stock worth $78,000 after acquiring an additional 123 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Axcelis Technologies in the second quarter worth about $82,000. Finally, Ancora Advisors LLC acquired a new stake in Axcelis Technologies in the 2nd quarter valued at about $95,000. Institutional investors own 89.98% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on the company. Wall Street Zen cut Axcelis Technologies from a “buy” rating to a “hold” rating in a research note on Saturday. Craig Hallum upgraded shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $140.00 price objective on the stock in a research note on Friday, November 6th. Zacks Research upgraded Axcelis Technologies from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. B. Riley Financial reiterated a “buy” rating and set a $140.00 price target (down from $165.00) on shares of Axcelis Technologies in a report on Friday, November 6th. Finally, Weiss Ratings raised Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 16th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Axcelis Technologies has a consensus rating of “Moderate Buy” and an average target price of $145.33.
Get Our Latest Research Report on Axcelis Technologies
Axcelis Technologies Stock Down 9.6%
Shares of ACLS opened at $90.36 on Friday. Axcelis Technologies, Inc. has a 12 month low of $73.60 and a 12 month high of $193.78. The stock has a market cap of $2.79 billion, a price-to-earnings ratio of 26.89, a P/E/G ratio of 1.25 and a beta of 1.88. The company has a 50-day moving average price of $113.37 and a two-hundred day moving average price of $123.32. The company has a quick ratio of 2.91, a current ratio of 4.43 and a debt-to-equity ratio of 0.04.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last issued its earnings results on Thursday, November 5th. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.11 by $0.15. Axcelis Technologies had a net margin of 11.74% and a return on equity of 11.51%. The company had revenue of $237.78 million during the quarter, compared to analysts’ expectations of $230.08 million. During the same quarter in the previous year, the company posted $1.21 EPS. The business’s revenue for the quarter was up 11.3% compared to the same quarter last year. Axcelis Technologies has set its Q4 2026 guidance at 1.500-1.500 EPS. Equities analysts predict that Axcelis Technologies, Inc. will post 3.82 EPS for the current fiscal year.
About Axcelis Technologies
Axcelis Technologies develops and manufactures ion implantation equipment used in semiconductor production. Its systems introduce precisely controlled impurities into silicon wafers, helping manufacturers create the electrical properties needed for semiconductor devices. The company’s product lineup includes its Purion family of ion implantation systems. Alongside equipment, Axcelis provides related services such as maintenance, upgrades, spare parts and technical support. Its products and services support semiconductor manufacturing for applications including power devices, which are used in areas such as electric vehicles and energy systems.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding ACLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report).
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
